{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:21:25Z","timestamp":1785392485255,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jid.2020.11.026","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T02:26:47Z","timestamp":1608085607000},"page":"1564-1572.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in Melanoma"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-711X","authenticated-orcid":false,"given":"Takeshi","family":"Fukumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0035-0938","authenticated-orcid":false,"given":"Jianhuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-9321","authenticated-orcid":false,"given":"Nail","family":"Fatkhutdinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-1235","authenticated-orcid":false,"given":"Pingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8444-8472","authenticated-orcid":false,"given":"Rajasekharan","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-0739","authenticated-orcid":false,"given":"Meenhard","family":"Herlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7255-2360","authenticated-orcid":false,"given":"Rugang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6784-2849","authenticated-orcid":false,"given":"Chikako","family":"Nishigori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.11.026_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2020.11.026_bib2","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900328","article-title":"Tumor-intrinsic response to IFNgamma shapes the tumor microenvironment and anti-PD-1 response in NSCLC","volume":"2","author":"Bullock","year":"2019","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.jid.2020.11.026_bib3","doi-asserted-by":"crossref","first-page":"45863","DOI":"10.18632\/oncotarget.10244","article-title":"Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression","volume":"7","author":"Duan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2020.11.026_bib4","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1158\/0008-5472.CAN-19-1302","article-title":"HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer","volume":"79","author":"Fukumoto","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.11.026_bib5","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1158\/0008-5472.CAN-18-3592","article-title":"N6-methylation of adenosine of FZD10 mRNA contributes to PARP inhibitor resistance","volume":"79","author":"Fukumoto","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.11.026_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.critrevonc.2016.02.001","article-title":"PD-L1 expression in cancer patients receiving anti PD-1\/PD-L1 antibodies: a systematic review and meta-analysis","volume":"100","author":"Gandini","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jid.2020.11.026_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.11.026_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2014.07.018","article-title":"Vulnerabilities of mutant SWI\/SNF complexes in cancer","volume":"26","author":"Helming","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.11.026_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41591-019-0382-x","article-title":"Genomic correlates of response to immune checkpoint blockade","volume":"25","author":"Keenan","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2020.11.026_bib10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.32140","article-title":"Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer","volume":"145","author":"Kim","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2020.11.026_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.11.026_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ijc.32744","article-title":"Association of PD-L1 expression status with the efficacy of PD-1\/PD-L1 inhibitors and overall survival in solid tumours: a systematic review and meta-analysis","volume":"147","author":"Liu","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2020.11.026_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/pcmr.12847","article-title":"Targeted therapy and immunotherapy: emerging biomarkers in metastatic melanoma","volume":"33","author":"LoRusso","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2020.11.026_bib14","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/ijc.27900","article-title":"Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma","volume":"132","author":"Manceau","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2020.11.026_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1615\/CritRevEukaryotGeneExpr.2014007882","article-title":"SWI\/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma","volume":"24","author":"Mehrotra","year":"2014","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.jid.2020.11.026_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.aan5951","article-title":"Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma","volume":"359","author":"Miao","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jid.2020.11.026_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/0008-5472.CAN-19-2830","article-title":"NAMPT inhibition suppresses cancer stem-like cells associated with therapy-induced senescence in ovarian cancer","volume":"80","author":"Nacarelli","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.11.026_bib18","first-page":"2030","article-title":"Phospho-STAT1 expression as a potential biomarker for anti-PD-1\/anti-PD-L1 immunotherapy for breast cancer","volume":"54","author":"Nakayama","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jid.2020.11.026_bib19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jhep.2016.12.026","article-title":"ARID2 modulates DNA damage response in human hepatocellular carcinoma cells","volume":"66","author":"Oba","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jid.2020.11.026_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/CMR.0000000000000589","article-title":"Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review","volume":"29","author":"Ouwerkerk","year":"2019","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2020.11.026_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11912-018-0733-7","article-title":"Molecular pathways in melanomagenesis: what we learned from next-generation sequencing approaches","volume":"20","author":"Palmieri","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jid.2020.11.026_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A\u00a0major chromatin regulator determines resistance of tumor cells to T cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jid.2020.11.026_bib23","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1096\/fj.11-195198","article-title":"Interferon-gamma biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells","volume":"26","author":"Satou","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2020.11.026_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2020.11.026_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","article-title":"ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade","volume":"24","author":"Shen","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2020.11.026_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4986","article-title":"The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer","volume":"244","author":"Shu","year":"2018","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jid.2020.11.026_bib27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nprot.2018.015","article-title":"Targeted in situ genome-wide profiling with high efficiency for low cell numbers","volume":"13","author":"Skene","year":"2018","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jid.2020.11.026_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jid.2020.11.026_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2020.11.026_bib30","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1101\/gad.1323805","article-title":"PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes","volume":"19","author":"Yan","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2020.11.026_bib31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.18632\/oncotarget.355","article-title":"ARID2: a new tumor suppressor gene in hepatocellular carcinoma","volume":"2","author":"Zhao","year":"2011","journal-title":"Oncotarget"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20323964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20323964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:21:49Z","timestamp":1758302509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20323964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022202X20323964"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.11.026","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}